Neurotrophic modulation of myelinated cutaneous innervation and mechanical sensory loss in diabetic mice

Neuroscience

Volumn 145, Issue 1, 2007, Pages 303-313

  Christianson, J A ^a   Ryals, J M ^b   Johnson, M S ^b   Dobrowsky, R T ^c   Wright, D E ^b  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF KANSAS   (United States)

Author keywords

dermis; diabetes; innervation; myelinated axon NGF; neuropathy; NT 3

Indexed keywords

INSULIN; MYELIN BASIC PROTEIN; NERVE GROWTH FACTOR; NEUROFILAMENT PROTEIN; NEUROTROPHIN; NEUROTROPHIN 3;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DIABETIC NEUROPATHY; DRUG EFFECT; HYPERGLYCEMIA; IMMUNOHISTOCHEMISTRY; INSULIN TREATMENT; MALE; MECHANICAL STIMULATION; MERKEL CELL; MYELINATED NERVE; NOCICEPTIVE STIMULATION; NONHUMAN; PRIORITY JOURNAL; RAT; SENSORY DYSFUNCTION; SKIN NERVE; STREPTOZOCIN DIABETES; TACTILE STIMULATION; WITHDRAWAL REFLEX;

ANIMALS; BLOOD GLUCOSE; BODY WEIGHT; DIABETES MELLITUS, EXPERIMENTAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; IMMUNOHISTOCHEMISTRY; INSULIN; MALE; MICE; MICE, INBRED C57BL; MYELIN BASIC PROTEINS; NERVE FIBERS, MYELINATED; NERVE GROWTH FACTORS; NEUROFILAMENT PROTEINS; PAIN MEASUREMENT; PHYSICAL STIMULATION; SENSATION DISORDERS; SKIN; TIME FACTORS;

EID: 33846877189     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2006.11.064     Document Type: Article

References (54)

1. Airaksinen M.S., Koltzenburg M., Lewin G.R., Masu Y., Helbig C., Wolf E., Brem G., Toyka K.V., Thoenen H., and Meyer M. Specific subtypes of cutaneous mechanoreceptors require neurotrophin-3 following peripheral target innervation. Neuron 16 (1996) 287-295
2. Akkina S.K., Patterson C.L., and Wright D.E. GDNF rescues nonpeptidergic unmyelinated primary afferents in streptozotocin-treated diabetic mice. Exp Neurol 167 (2001) 173-182
3. Albers K.M., Perrone T.N., Goodness T.P., Jones M.E., Green M.A., and Davis B.M. Cutaneous overexpression of NT-3 increases sensory and sympathetic neuron number and enhances touch dome and hair follicle innervation. J Cell Biol 134 (1996) 487-497
4. Apfel S.C. Neurotrophic factors in peripheral neuropathies: Therapeutic implications. Brain Pathol 9 (1999) 393-413
5. Apfel S.C. Nerve growth factor for the treatment of diabetic neuropathy: what went wrong, what went right, and what does the future hold?. Int Rev Neurobiol (2002) 393-413
6. Brown M.J., Sumner A.J., Greene D.A., Diamond S.M., and Asbury A.K. Distal neuropathy in experimental diabetes mellitus. Ann Neurol 8 (1980) 168-178
7. Brown M.J., and Asbury A.K. Diabetic neuropathy. Ann Neurol 15 (1984) 2-12
8. Cain D.M., Khasabov S.G., and Simone D.A. Response properties of mechanoreceptors and nociceptors in mouse glabrous skin: an in vivo study. J Neurophysiol 85 (2001) 1561-1574
9. Calcutt N.A., Jorge M.C., Yaksh T.L., and Chaplan S.R. Tactile allodynia and formalin hyperalgesia in streptozotocin-diabetic rats: effects of insulin, aldose reductase inhibition and lidocaine. Pain 68 (1996) 293-299
10. Christianson J.A., Ryals J.M., McCarson K.E., and Wright D.E. Beneficial actions of neurotrophin treatment on diabetes-induced hypoalgesia in mice. J Pain 4 (2003) 493-504
11. Christianson J.A., Riekhof J.T., and Wright D.E. Restorative effects of neurotrophin treatment on diabetes-induced cutaneous axon loss in mice. Exp Neurol 179 (2003) 188-199
12. Courteix C., Eschalier A., and Lavarenne J. Streptozocin-induced diabetic rats: behavioural evidence for a model of chronic pain. Pain 53 (1993) 81-88
13. DCCT Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 329 (1993) 977-986
14. Fang X., Djouhri L., McMullan S., Berry C., Okuse K., Waxman S.G., and Lawson S.N. TrkA is expressed in nociceptive neurons and influences electrophysiological properties via Nav1.8 expression in rapidly conducting nociceptors. J Neurosci 25 (2005) 4868-4878
15. Fernyhough P., Gallagher A., Averill S.A., Priestley J.V., Hounsom L., Patel J., and Tomlinson D.R. Aberrant neurofilament phosphorylation in sensory neurons of rats with diabetic neuropathy. Diabetes 48 (1999) 881-889
16. Fernyhough P., Diemel L.T., and Tomlinson D.R. Target tissue production and axonal transport of neurotrophin-3 are reduced in streptozotocin-diabetic rats. Diabetologia 41 (1998) 300-306
17. Fox A., Eastwood C., Gentry C., Manning D., and Urban L. Critical evaluation of the streptozotocin model of painful diabetic neuropathy in the rat. Pain 81 (1999) 307-316
18. Fundin B.T., Silos-Santiago I., Ernfors P., Fagan A.M., Aldskogius H., DeChiara T.M., Phillips H.S., Barbacid M., Yancopoulos G.D., and Rice F.L. Differential dependency of cutaneous mechanoreceptors on neurotrophins, trk receptors, and P75 LNGFR. Dev Biol 190 (1997) 94-116
19. Funfschilling U., Ng Y.G., Zang K., Miyazaki J., Reichardt L.F., and Rice F.L. TrkC kinase expression in distinct subsets of cutaneous trigeminal innervation and nonneuronal cells. J Comp Neurol 480 (2004) 392-414
20. Gandhi R., Ryals J.M., and Wright D.E. Neurotrophin-3 reverses chronic mechanical hyperalgesia induced by intramuscular acid injection. J Neurosci 24 (2004) 9405-9413
21. Gratto K.A., and Verge V.M. Neurotrophin-3 down-regulates trkA mRNA, NGF high-affinity binding sites, and associated phenotype in adult DRG neurons. Eur J Neurosci 18 (2003) 1535-1548
22. Greene D.A., Stevens M.J., and Feldman E.L. Diabetic neuropathy: scope of the syndrome. Am J Med 107 (1999) 2S-8S
23. Hellweg R., and Hartung H.D. Endogenous levels of nerve growth factor (NGF) are altered in experimental diabetes mellitus: a possible role for NGF in the pathogenesis of diabetic neuropathy. J Neurosci Res 26 (1990) 258-267
24. Herrmann D.N., Griffin J.W., Hauer P., Cornblath D.R., and McArthur J.C. Epidermal nerve fiber density and sural nerve morphometry in peripheral neuropathies. Neurology 53 (1999) 1634-1640
25. Hirai A., Yasuda H., Joko M., Maeda T., and Kikkawa R. Evaluation of diabetic neuropathy through the quantitation of cutaneous nerves. J Neurol Sci 172 (2000) 55-62
26. Huang T.J., Price S.A., Chilton L., Calcutt N.A., Tomlinson D.R., Verkhratsky A., and Fernyhough P. Insulin prevents depolarization of the mitochondrial inner membrane in sensory neurons of type 1 diabetic rats in the presence of sustained hyperglycemia. Diabetes 52 (2003) 2129-2136
27. Jakobsen J., Brimijoin S., Skau K., Sidenius P., and Wells D. Retrograde axonal transport of transmitter enzymes, fucose-labeled protein, and nerve growth factor in streptozotocin-diabetic rats. Diabetes 30 (1981) 797-803
28. Kennedy W.R., Wendelschafer-Crabb G., and Johnson T. Quantitation of epidermal nerves in diabetic neuropathy. Neurology 47 (1996) 1042-1048
29. Khan G.M., Chen S.R., and Pan H.L. Role of primary afferent nerves in allodynia caused by diabetic neuropathy in rats. Neuroscience 114 2 (2002) 291-299
30. Koltzenburg M., Stucky C.L., and Lewin G.R. Receptive properties of mouse sensory neurons innervating hairy skin. J Neurophysiol 78 (1997) 1841-1850
31. Krimm R.F., Davis B.M., Woodbury C.J., and Albers K.M. NT3 expressed in skin causes enhancement of SA1 sensory neurons that leads to postnatal enhancement of Merkel cells. J Comp Neurol 471 (2004) 352-360
32. Lauria G., Cornblath D.R., Johansson O., McArthur J.C., Mellgren S.I., Nolano M., Rosenberg N., and Sommer C. EFNS guidelines on the use of skin biopsy in the diagnosis of peripheral neuropathy. Eur J Neurol 12 (2005) 747-758
33. Leinninger G.M., Vincent A.M., and Feldman E.L. The role of growth factors in diabetic peripheral neuropathy. J Peripher Nerv Syst 9 (2004) 26-53
34. McCarthy B.G., Hsieh S.T., Stocks A., Hauer P., Macko C., Cornblath D.R., Griffin J.W., and McArthur J.C. Cutaneous innervation in sensory neuropathies: evaluation by skin biopsy. Neurology 45 10 (1995) 1848-1855
35. Mizisin A.P., Shelton G.D., Wagner S., Rusbridge C., and Powell H.C. Myelin splitting, Schwann cell injury and demyelination in feline diabetic neuropathy. Acta Neuropathol (Berl) 95 (1998) 171-174
36. Mizisin A.P., Calcutt N.A., Tomlinson D.R., Gallagher A., and Fernyhough P. Neurotrophin-3 reverses nerve conduction velocity deficits in streptozotocin-diabetic rats. Peripher Nerv Syst 4 (1999) 211-221
37. Mizisin A.P., Kalichman M.W., Bache M., Dines K.C., and DiStefano P.S. NT-3 attenuates functional and structural disorders in sensory nerves of galactose-fed rats. J Neuropathol Exp Neurol 57 (1998) 803-813
38. Mueller M.J. Identifying patients with diabetes mellitus who are at risk for lower-extremity complications: use of Semmes-Weinstein monofilaments. Phys Ther 76 (1996) 68-71
39. Norrsell U., Eliasson B., Frizell M., Wallin B.G., Wesslau C., and Olausson H. Tactile directional sensibility and diabetic neuropathy. Muscle Nerve 24 (2001) 1496-1502
40. Ochodnicka E., Ochdnicky M., Belej K., Fusekova E., and Bosel'ova L. Quantitative analysis of myelinated nerve fibers of peripheral nerve in streptozotocin-induced diabetes mellitus. Mol Chem Neuropathol 25 (1995) 225-233
41. Petruska J.C., and Mendell L.M. The many functions of nerve growth factor: multiple actions on nociceptors. Neurosci Lett 361 (2004) 168-171
42. Romanovsky D., Hastings S.L., Stimers J.R., and Dobretsov M. Relevance of hyperglycemia to early mechanical hyperalgesia in streptozotocin-induced diabetes. J Peripher Nerv Syst 9 (2004) 62-69
43. Russell J.W., Windebank A.J., Schenone A., and Feldman E.L. Insulin-like growth factor-I prevents apoptosis in neurons after nerve growth factor withdrawal. J Neurobiol 36 (1998) 455-467
44. Sayers N.M., Beswick L.J., Middlemas A., Calcutt N.A., Mizisin A.P., Tomlinson D.R., and Fernyhough P. Neurotrophin-3 prevents the proximal accumulation of neurofilament proteins in sensory neurons of streptozocin-induced diabetic rats. Diabetes 52 (2003) 2372-2380
45. Schmidt R.E., Plurad S.B., Saffitz J.E., Grabau G.G., and Yip H.K. Retrograde axonal transport of 125I-nerve growth factor in rat ileal mesenteric nerves. Effect of streptozocin diabetes. Diabetes 34 (1985) 1230-1240
46. Sima A.A., Nathaniel V., Bril V., McEwen T.A., and Greene D.A. Histopathological heterogeneity of neuropathy in insulin-dependent and non-insulin-dependent diabetes, and demonstration of axo-glial dysjunction in human diabetic neuropathy. J Clin Invest 81 (1988) 349-364
47. Snider W.D., and McMahon S.B. Tackling pain at the source: new ideas about nociceptors. Neuron 20 (1998) 629-632
48. Stucky C.L., Koltzenburg M., Schneider M., Engle M.G., Albers K.M., and Davis B.M. Overexpression of nerve growth factor in skin selectively affects the survival and functional properties of nociceptors. J Neurosci 19 (1999) 8509-8516
49. Vinik A.I. Diabetic neuropathy: pathogenesis and therapy. Am J Med 107 (1999) 17S-26S
50. Weis J., Dimpfel W., and Schroder J.M. Nerve conduction changes and fine structural alterations of extra- and intrafusal muscle and nerve fibers in streptozotocin diabetic rats. Muscle Nerve 18 (1995) 175-184
51. Wilson-Gerwing T.D., Dmyterko M.V., Zochodne D.W., Johnston J.M., and Verge V.M. Neurotrophin-3 suppresses thermal hyperalgesia associated with neuropathic pain and attenuates transient receptor potential vanilloid receptor-1 expression in adult sensory neurons. J Neurosci 25 (2005) 758-767
52. Wright D.E., Ryals J.M., McCarson K.E., and Christianson J.A. Diabetes-induced expression of activating transcription factor 3 in mouse primary sensory neurons. J Peripher Nerv Syst 9 (2004) 242-254
53. Wright D.E., and Snider W.D. Neurotrophin receptor mRNA expression defines distinct populations of neurons in rat dorsal root ganglia. J Comp Neurol 351 (1995) 329-338
54. Yagihashi S., Kamijo M., and Watanabe K. Reduced myelinated fiber size correlates with loss of axonal neurofilaments in peripheral nerve of chronically streptozotocin diabetic rats. Am J Pathol 136 (1990) 1365-1373